
Co-Diagnostics CODX
$ 4.4
101.83%
Quarterly report 2025-Q3
added 11-13-2025
Country |
|
IPO year |
2017 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
29.3 M |
Market Cap[1] |
$ 129 M |
EBITDA (LTM) |
$ -32.7 M |
P/E (LTM) |
-4.63 |
P/S (LTM) |
129.16 |
EPS (LTM) |
-0.95 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 123.79 | -0.43 % | $ 19.7 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.13 | -2.74 % | $ 4.89 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 25.75 | 3.0 % | $ 715 M | Nasdaq Global Market,SPB | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 8.1 | 1.76 % | $ 1.04 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
National Research Corporation
NRC
|
$ 17.51 | 1.1 % | $ 392 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 200.09 | 2.46 % | $ 19.7 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
OPKO Health
OPK
|
$ 1.15 | 2.68 % | $ 798 M | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 7.61 | 4.82 % | $ 451 M | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 158.0 | 2.86 % | $ 7.83 B | NYSE,SPB | ||
|
IQVIA Holdings
IQV
|
$ 166.96 | 0.54 % | $ 28.7 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 75.73 | -0.92 % | $ 5.11 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
IDEXX Laboratories
IDXX
|
$ 578.51 | 0.22 % | $ 46.5 B | Nasdaq Global Select Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.46 | 26.96 % | $ 1.86 M | Nasdaq Capital Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 456.93 | 0.98 % | $ 13.2 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 6.62 | 2.16 % | $ 276 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 13.88 | 2.81 % | $ 3.94 B | Nasdaq Global Select Market | ||
|
Agilent Technologies
A
|
$ 112.02 | 0.65 % | $ 34.1 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 100.35 | 0.65 % | $ 8.28 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 31.72 | -4.52 % | $ 1.61 B | Nasdaq Capital Market | ||
|
DarioHealth Corp.
DRIO
|
$ 7.5 | -6.13 % | $ 29.9 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 84.9 | -0.33 % | $ 10.6 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.66 | 1.75 % | $ 432 M | Nasdaq Global Select Market,SPB | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Neuronetics
STIM
|
$ 1.6 | 10.34 % | $ 106 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Mettler-Toledo International
MTD
|
$ 1 239.07 | 2.87 % | $ 25.5 B | NYSE,SPB | ||
|
CareDx, Inc
CDNA
|
$ 17.56 | 2.39 % | $ 936 M | Nasdaq Global Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 3.48 | 0.87 % | $ 1.87 M | Nasdaq Global Select Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 478.12 | 0.79 % | $ 180 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 106.75 | 0.67 % | $ 4.21 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 264.42 | 0.54 % | $ 22 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.